Company Name, Ticker, Industry, else..
STOCKS
HOME
Stock Profile
Company Fundamentals
Financial Results
CEMP's Officers & Directors
Company Descriptions
Charts & Quotes
News
Company Suppliers
Company Competitors
Company Markets Customers
Economic Indicators
INDUSTRIES
Revenue Growth by Industry
Net Income Growth by Industry
Net Margin by Industry
PE by Industry
Total Debt to Equity by Industry
Revenue per Employee by Industry
Return On Assets by Industry
Performance by Industry
Growth Rates by Industry
Profitability by Industry
Valuation by Industry
Financial Strength by Industry
ECONOMY
Advance Monthly Sales
Consumer Price Index CPI
Producer Price Index PPI
Retail Inventories
Personal Income
Gross Domestic Product GDP
Money Supply
Industrial Production
Productivity
Employment Situation
U.S. International Trade
Factory orders
Durable Goods
Construction Spending
Housing Starts
Vehicle Unit Sales
MARKETS
Stocks
Cryptocurrencies
Sectors & Industries
Commodities
Foreign Exchange
Stocks in 2023
SCREENING
Stock Performance Screening
Profitability Screening
Valuation Screening
Dividend Screening
Financial Strength Screening
Efficiency Screening
Largest Companies
Mgmnt. Effectivness Screening
NEWS
Stock News
Economy News
GLOSSARY
Financial Terms
Technical Analysis
Fundamental Analysis
Energy Terms
Manufacturing Terms
Transportation Terms
Health Care
Insurance Terms
Economy Terms
Hotel & Leisure Terms
HELP
Company Profile
Melinta Therapeutics, Inc. News
Melinta Therapeutics, Inc.'s ROI
Melinta Therapeutics, Inc.'s Revenue per Employee
Melinta Therapeutics, Inc. Business Description
Melinta Therapeutics, Inc. Executive Officers
Economic Indicators
Fundamentals
Melinta Therapeutics, Inc. Growth Rates
Melinta Therapeutics, Inc. Profitability
Melinta Therapeutics, Inc. Valuation
Melinta Therapeutics, Inc. Management Effectiveness
Melinta Therapeutics, Inc. Financial Strength
Melinta Therapeutics, Inc. Efficiency
Melinta Therapeutics, Inc. Dividend
Financials
Melinta Therapeutics, Inc. Business Segments
Melinta Therapeutics, Inc. Income Statement
Melinta Therapeutics, Inc. Balance Sheets
Melinta Therapeutics, Inc. Cash Flow Statement
Melinta Therapeutics, Inc. Geographic Information
Suppliers
Melinta Therapeutics, Inc. Suppliers Performance
CEMP Suppliers Stock Performance
CEMP Suppliers Growth Rates
CEMP Suppliers Data
CEMP Suppliers Efficiency
CEMP Suppliers Management Effectiveness
CEMP Suppliers Valuation
CEMP Suppliers by Companys' Segments
Competition
Competition by Companys' Segments
Melinta Therapeutics, Inc. Market Share
Melinta Therapeutics, Inc. Competition Performance
Melinta Therapeutics, Inc. Competitors Results
CEMP Competitors Stock Performance
CEMP Competitors Growth Rates
CEMP Workforce Efficiency at the Competitors
CEMP Competitors Efficiency
CEMP Competitors Management Effectiveness
CEMP Competitors Valuation
Customers & Markets
Melinta Therapeutics, Inc. Customers Demand
CEMP Customers Expenditure Growth Rates
CEMP Customers Performance
CEMP Customers Stock Performance
CEMP Customers Growth Rates
CEMP Workforce Efficiency at the Customers
CEMP Customers Efficiency
CEMP Customers Management Effectiveness
CEMP Customers Valuation
CEMP Customers by Companys' Segments
Charts & Quotes
Melinta Therapeutics, Inc. Comparison Charts
CEMP OHLC Charts
CEMP's Tehnical Upper Indicators
CEMP's Tehnical Lower Indicators
CEMP's Weekly Charts
CEMP's Monthly Charts
Melinta Therapeutics, Inc.'s Profile
Company Charts and Quotes
Melinta Therapeutics, Inc. News
Melinta Therapeutics, Inc.'s Geographic Information
Melinta Therapeutics, Inc.'s Income Statement
Melinta Therapeutics, Inc.'s Balance Sheets
Melinta Therapeutics, Inc.'s Cash Flow Statement
Melinta Therapeutics, Inc.'s Profitability
Melinta Therapeutics, Inc.'s Financials
CEMP's Operating Margin
Melinta Therapeutics, Inc.'s Suppliers
Melinta Therapeutics, Inc.'s Competitors
Melinta Therapeutics, Inc.'s Markets & Customers
Melinta Therapeutics, Inc.'s Market Share
CEMP's Suppliers Management Effectiveness
CEMP's Competitors Efficiency
CEMP's Charts Rate of Change (ROC)
CEMP's Customers Demand
Economic Indicators
Growth Rates by Industry
Stock Performance Screening
Markets at a Glance
Stocks
Cryptocurrencies
Sectors & Industries
Commodities
Foreign Exchange
Stocks in 2023
Personal Income
News
Economy News
Stock News
Health Care
At a Glance
Growth Rates
• Revenue Y/Y
• Op. Income Y/Y
• Cop. Income Y/Y
• Net Income Y/Y
• Eps Cop. Y/Y
• Eps Net Y/Y
• Free Cash Flow Y/Y
• Cash Flow Y/Y
• Capex Y/Y
• OP. Inc. Y/Y Annual
Profitability
Valuation Comparisons
Management Effectiveness
Financial Strength
Efficiency
Dividend Comparisons
Melinta Therapeutics, Inc.
(
CEMP
)
Other Ticker:
Sector
•
Healthcare
Industry
•
Major Pharmaceutical Preparations
Industry
•
Major Pharmaceutical Preparations
Sector
•
Healthcare
Melinta Therapeutics's Yearly Operating Income Growth 5 Years
Select the Comparisons :
None ▼
Growth Rates
Profitability
Valuation Comparisons
Management Effectiveness
Financial Strength
Efficiency
Dividend Comparisons
Select the Ratio:
Annual Operating Income Annual Growth Rates Y/Y▼
Revenue Y/Y
Op. Income Y/Y
Income from Cont. Operations Y/Y
Net Income Y/Y
Effective Tax Rate
Eps Cop. Y/Y
Eps Net Y/Y
Free Cash Flow Y/Y
Cash Flow Y/Y
Capex Y/Y
Gross Margin
EBITDA Margin
Operating Margin
Net Margin
Pre-Tax Margin
Free Cash Flow Margin
Cash Flow Margin
P/E Ratio TTM
P/S Ratio TTM
P/CF Ratio TTM
P/FCF Ratio TTM
Price to Book MRQ
Price to Tangible Book
ROA Quarterly
ROI Quarterly
ROE Quarterly
Quick Ratio
Quick Ratio TTM
Working Capital
Working Capital TTM
Long Term Debt to Equity
Long Term Debt to Equity TTM
Debt to Equity
Debt to Equity TTM
Leverage Ratio
Leverage Ratio TTM
Tangible Leverage Ratio
Interest Coverage
Debt Coverage
Working Capital Per Revenue
Sales per Employee
Income per Employee
Inventory to Sales
Inventory Turnover
Asset Turnover
Receivables Turnover
Dividend Growth
Dividend Payout
Cumulative Payout
Annual Dividend Payout
Revenue Annual Growth
Operating Income Annual Growth
Income from Continued Operations Annual Growth
Net Income Annual Growth
Eps Continued Operations Annual Growth
Eps Net Annual Growth
Free Cash Flow Annual Growth
Cash Flow Annual Growth
Capex Annual Growth
None ▼
Growth Rates
Profitability
Valuation Comparisons
Management Effectiveness
Financial Strength
Efficiency
Dividend Comparisons
Annual Operating Income Annual Growth Rates Y/Y▼
Revenue Y/Y
Op. Income Y/Y
Income from Cont. Operations Y/Y
Net Income Y/Y
Effective Tax Rate
Eps Cop. Y/Y
Eps Net Y/Y
Free Cash Flow Y/Y
Cash Flow Y/Y
Capex Y/Y
Gross Margin
EBITDA Margin
Operating Margin
Net Margin
Pre-Tax Margin
Free Cash Flow Margin
Cash Flow Margin
P/E Ratio TTM
P/S Ratio TTM
P/CF Ratio TTM
P/FCF Ratio TTM
Price to Book MRQ
Price to Tangible Book
ROA Quarterly
ROI Quarterly
ROE Quarterly
Quick Ratio
Quick Ratio TTM
Working Capital
Working Capital TTM
Long Term Debt to Equity
Long Term Debt to Equity TTM
Debt to Equity
Debt to Equity TTM
Leverage Ratio
Leverage Ratio TTM
Tangible Leverage Ratio
Interest Coverage
Debt Coverage
Working Capital Per Revenue
Sales per Employee
Income per Employee
Inventory to Sales
Inventory Turnover
Asset Turnover
Receivables Turnover
Dividend Growth
Dividend Payout
Cumulative Payout
Annual Dividend Payout
Revenue Annual Growth
Operating Income Annual Growth
Income from Continued Operations Annual Growth
Net Income Annual Growth
Eps Continued Operations Annual Growth
Eps Net Annual Growth
Free Cash Flow Annual Growth
Cash Flow Annual Growth
Capex Annual Growth
CEMP Annual Operating Income Growth
2018
2017
2016
2015
2014
Y / Y Annual Operating Income Change
-
-
-
-
-
Annual Operating Income (in millions $)
$-158.44
$-78.94
$-117.21
$-88.92
$-59.40
CEMP Company Profile
>>
Back to CEMP Fundamentals at a Glance
>>
Back to CEMP Growth Comparisons
Annual Operating Income Growth Comment
Melinta Therapeutics, Inc.
realized Operating Loss.
Melinta Therapeutics Annual Income Statement
You need to upgrade your Flash Player
Companies with similar 2018 Annual Operating Income within Healthcare Sector
Y/Y Operating Income Growth %
2018 Annual Operating Income
Davita Inc
-15.83 %
$ 1,525.824 millions
Becton Dickinson And Company
1.29 %
$ 1,497.000 millions
Mylan N v
-36.98 %
$ 905.600 millions
Mettler toledo International Inc
-30.19 %
$ 1,001.683 millions
Boston Scientific Corporation
17.20 %
$ 1,506.000 millions
Universal Health Services Inc
-8.20 %
$ 1,175.262 millions
Quest Diagnostics Inc
-5.49 %
$ 1,101.000 millions
Intuitive Surgical Inc
13.73 %
$ 1,199.400 millions
Edwards Lifesciences Corporation
-28.47 %
$ 748.200 millions
Henry Schein Inc
-12.37 %
$ 753.052 millions
Agilent Technologies inc
10.34 %
$ 928.000 millions
United Therapeutics Corporation
-1.17 %
$ 805.400 millions
Zimmer Biomet Holdings Inc
-95.82 %
$ 33.800 millions
Iqvia Holdings Inc
3.06 %
$ 741.000 millions
Waters Corp
11.77 %
$ 739.774 millions
Illumina Inc
45.71 %
$ 883.000 millions
Jazz Pharmaceuticals Plc
16.26 %
$ 614.838 millions
Carlisle Companies Incorporated
0.65 %
$ 509.000 millions
Pediatrix Medical Group Inc
-7.13 %
$ 445.848 millions
The Cooper Companies Inc
-6.06 %
$ 403.100 millions
Resmed Inc
27.25 %
$ 541.831 millions
Idexx Laboratories Inc
18.96 %
$ 491.335 millions
Teleflex Incorporated
-13.59 %
$ 321.704 millions
Select Medical Holdings Corp
17.25 %
$ 417.279 millions
Align Technology inc
31.94 %
$ 466.564 millions
Varian Medical Systems Inc
29.16 %
$ 441.600 millions
Icon Plc
10.35 %
$ 373.357 millions
Revvity Inc
6.26 %
$ 323.884 millions
Charles River Laboratories International inc
15.26 %
$ 331.383 millions
Hill rom Holdings Inc
5.89 %
$ 289.500 millions
Steris Plc
77.27 %
$ 403.454 millions
Surgery Partners Inc
-60.38 %
$ 77.838 millions
Pra Health Sciences Inc
59.63 %
$ 281.312 millions
Exelixis Inc
164.51 %
$ 438.855 millions
Magellan Health inc
-58.46 %
$ 64.522 millions
Healthcare Services Group Inc
-38.62 %
$ 77.879 millions
Vertex Pharmaceuticals Inc
415.36 %
$ 635.150 millions
Nuvasive Inc
-52.21 %
$ 54.168 millions
Iveric Bio Inc